Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Molecular Ecology|August 30, 2016
Neuroendocrine profiles associated with discrete behavioural variation in Symphodus ocellatus, a species with male alternative reproductive tacticsB M Nugent, K A Stiver, S H Alonzo, et al.European Journal of Pharmacology|March 14, 2001
Cannabinoid CB(1) receptor upregulation in a rat model of chronic neuropathic painA Siegling, H A Hofmann, D Denzer, et al.European Journal of Pharmacology|November 8, 2001
Metabotropic glutamate mGlu1 receptor mRNA expression in dorsal root ganglia of rats after peripheral nerve injuryH A Hofmann, A Siegling, D Denzer, et al.Journal of Neuroendocrinology|May 2, 2013
Neuroendocrine mechanisms underlying sensory integration of social signalsL A O'Connell, M M Rigney, D W Dykstra, et al.Journal of Neurophysiology|April 1, 2011
Serotonergic modulation of startle-escape plasticity in an African cichlid fish: a single-cell molecular and physiological analysis of a vital neural circuitK W Whitaker, H Neumeister, L S Huffman, et al.The Journal of Laryngology and Otology|November 1, 1987
A method for preparation of fibrin glueL H Durham, D J Willatt, M W Yung, et al.Blood|December 10, 1999
A point mutation Thr(799)Met on the alpha(2) integrin leads to the formation of new human platelet alloantigen Sit(a) and affects collagen-induced aggregationS Santoso, J Amrhein, H A Hofmann, et al.Journal of Evolutionary Biology|September 30, 2011
The role of physiology in the divergence of two incipient cichlid speciesP D Dijkstra, G F Wiegertjes, M Forlenza, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
A randomized British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphomaD C Linch, P Smith, B W Hancock, et al.British Journal of Cancer|July 1, 1996
A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: a British National Lymphoma Investigation reportD C Linch, B Vaughan Hudson, B W Hancock, et al.Pageof 4